🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cystic Fibrosis Lung Disease

Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients NCT02965326NA1 site📍 Paris Hôpital Necker-Enfants Malades · Tests: Nasal swab; rectal biopsy. Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy NCT06996951Phase 31 site📍 Indianapolis Indiana University · Tests: STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID, CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID GRAnulomatous MAstitis REGistry Study NCT07422870n/a2 sites📍 Düsseldorf📍 Lübeck European Breast Cancer Research Association of Surgical Tri… Regional Monitoring of CF Lung Disease NCT06339593EARLY Phase 11 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Airway-clearance vest, Hyperpolarized Xe129 Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association. NCT06356246n/a1 site📍 Ivry-sur-Seine Assistance Publique - Hôpitaux de Paris Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening NCT02270476n/a4 sites📍 Heidelberg📍 Giessen📍 Hanover Heidelberg University Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis NCT06163482n/a1 site📍 Cincinnati University of Cincinnati · Tests: Mixed meal ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health NCT07505797n/a2 sites📍 Sacramento📍 Cypress iSono Health, Inc. · Tests: ATUSA 3D Automated Breast Ultrasound System Cystic Fibrosis in the Kidney: Monitoring the Effectiveness of Elexacaftor/tezacaftor/ivacaftor in Urine After a Short Pause of Therapy NCT05818319NA1 site📍 Aarhus C University of Aarhus · Tests: 12 hours ETI pause, 36 hours ETI pause, 60 hours ETI pause Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis NCT07508904NA1 site📍 Lahore Riphah International University · Tests: Arm Cycle Ergometry, Leg Cycle Ergometry Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled Trial NCT06457451NA4 sites📍 Angers📍 Roscoff📍 Tours University Hospital, Tours · Tests: DIAPASOM program Autogenic Drainage Versus Mechanical Percussion in Children With Cystic Fibrosis NCT07729787NA1 site📍 Multan Khurd Riphah International University · Tests: Autogenic Drainage, Mechanical Percussion Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor NCT07314229NA1 site📍 Lille University Hospital, Lille · Tests: Measurement of resistance through forced oscillations and continuous measurement of ventilation and inspiratory capacit… Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study NCT05548283Phase 460 sites📍 Birmingham📍 Tucson📍 La Jolla Chris Goss · Tests: Beta-lactam antibiotic, Aminoglycoside Regional Phenotyping of CF and Non-CF Bronchiectasis NCT04793867n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Xenon Rare CFTR Mutation Cell Collection Protocol (RARE) NCT03161808n/a1 site📍 Birmingham George Solomon Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis NCT07342920n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Measures of Respiratory Health Registry NCT05501587n/a1 site📍 Vancouver University of British Columbia Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine NCT04137133NA1 site📍 Roscoff University Hospital, Brest · Tests: collection A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders NCT07889973n/a3 sites📍 Catania📍 Genova📍 Milan Istituto Giannina Gaslini Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score) NCT03052283n/a2 sites📍 Brandenburg an der Havel📍 Brandenburg an der Havel Medizinische Hochschule Brandenburg Theodor Fontane · Tests: Questionnaire Patient Reported Outcome Measure (PROM) Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis NCT06602869n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Scheduled visit (V1) Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population NCT07303621n/a1 site📍 Bron Hospices Civils de Lyon · Tests: There is no intervention as this is a prospective pharmacokinetics study. Trikafta Exercise Study in Cystic Fibrosis NCT05279040n/a1 site📍 Vancouver University of British Columbia · Tests: Trikafta Evaluation of New Device for Beta-adrenergic Sweat Test in the Context of Stratification of Patient With Cystic Fibrosis NCT06836453NA1 site📍 Brussels Cliniques universitaires Saint-Luc- Université Catholique d… · Tests: Sweat stimulation and secretion quantification Health Outcomes of Parents With Cystic Fibrosis-Aim 2 NCT06296394n/a18 sites📍 Birmingham📍 Denver📍 Evanston University of Pittsburgh · Tests: Parenthood Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF NCT05200429n/a2 sites📍 Vancouver📍 Vancouver University of British Columbia · Tests: Trikafta NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria NCT05017766n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: analysis of antimicrobial resistance Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis NCT06616857NA1 site📍 Jacksonville Nemours Children's Clinic · Tests: NUDGE, Education Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years NCT07485543EARLY Phase 11 site📍 Beijing Peking Union Medical College Hospital · Tests: BMD003 (CFTR mRNA)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy